Boon, Thierry
de Duve Institute,
Belgium
2025 Rank: 12470
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 443 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12470 | 13483 |
| Total Cites | 30579 | 33870 |
| H-index | 85 | 90 |
| Hm-index | 27 | 28 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 257 | 260 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 3887 | 4041 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 19074 | 20869 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 16901 | 17417 |
| Ratio of Total Citations to Distinct Citing Papers | 1.81 | 1.94 |
| Self-Citation Percentage |
9.72%
|
|
Boon, Thierry
Université Catholique de Louvain,
Belgium
2024 Rank: 11435
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 426 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11435 | 12310 |
| Total Cites | 29884 | 33180 |
| H-index | 85 | 90 |
| Hm-index | 26 | 28 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 253 | 256 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 3831 | 3985 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 18706 | 20497 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 16402 | 16920 |
| Ratio of Total Citations to Distinct Citing Papers | 1.82 | 1.96 |
| Self-Citation Percentage |
9.93%
|
|
Boon, Thierry
de Duve Institute,
Belgium
2023 Rank: 10397
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 395 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10397 | 11119 |
| Total Cites | 29192 | 32479 |
| H-index | 84 | 90 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 252 | 255 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 3792 | 3946 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 18341 | 20129 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 15875 | 16387 |
| Ratio of Total Citations to Distinct Citing Papers | 1.84 | 1.98 |
| Self-Citation Percentage |
10.12%
|
|
Boon, Thierry
de Duve Institute,
Belgium
2022 Rank: 9165
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 364 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9165 | 9910 |
| Total Cites | 28339 | 31603 |
| H-index | 83 | 89 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 248 | 251 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 3721 | 3875 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 17931 | 19706 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 15254 | 15758 |
| Ratio of Total Citations to Distinct Citing Papers | 1.86 | 2.01 |
| Self-Citation Percentage |
10.33%
|
|
Boon, Thierry
de Duve Institute,
Belgium
2021 Rank: 8825
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 345 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8825 | 9395 |
| Total Cites | 27775 | 31009 |
| H-index | 82 | 89 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 243 | 246 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 3650 | 3803 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 17582 | 19342 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 14920 | 15411 |
| Ratio of Total Citations to Distinct Citing Papers | 1.86 | 2.01 |
| Self-Citation Percentage |
10.43%
|
|
Boon, Thierry
de Duve Institute,
Belgium
2020 Rank: 7735
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 296 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7735 | 8041 |
| Total Cites | 27183 | 30511 |
| H-index | 82 | 89 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 239 | 242 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 3578 | 3730 |
| Number of Single+First+Last Authored Papers | 139 | 139 |
| Total Cites to Single+First+Last Authored Papers | 17039 | 18803 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 14148 | 14635 |
| Ratio of Total Citations to Distinct Citing Papers | 1.92 | 2.08 |
| Self-Citation Percentage |
10.91%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.